KenSujinHoMD
Infectious Disease • Pittsburgh, PAInstructor, Medicine, University of Pittsburgh School of Medicine
Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Lothrop St
Falk Medical Building Suite 3a
Pittsburgh, PA 15213Phone+1 412-648-6924
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 2008 - 2010- UPMC Medical EducationResidency, Internal Medicine, 2004 - 2007
University of Maryland School of MedicineClass of 2004
Certifications & Licensure
PA State Medical License 2004 - 2024
NJ State Medical License 2021 - 2023
MD State Medical License 2006 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Clinical Trials
- Dipyridamole for Immune Activation in HIV Start of enrollment: 2014 Jul 01
- Optimization of a Tenofovir Enema for HIV Prevention Start of enrollment: 2016 Oct 01
- Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults Start of enrollment: 2018 May 10
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsIdeal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.Pamela S Douglas, Sara McCallum, Michael T Lu, Triin Umbleja, Kathleen V Fitch
AIDS. 2023-03-01 - 3 citationsHepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.Jordan E Lake, Jana Taron, Heather J Ribaudo, Jorge Leon-Cruz, Netanya S Utay
AIDS. 2023-11-15 - 40 citationsMTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.Ross D. Cranston, Javier R. Lama, Barbra A. Richardson, Alex Carballo-Diéguez, Ratiya Pamela Kunjara Na Ayudhya
Clinical Infectious Diseases. 2016-12-16
Journal Articles
- Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals Following Tenofovir Disoproxil Fumarate InitiationRebecca Scherzer, Frank J Palella, Vasantha Jotwani, Mardge H Cohen, Carl Grunfeld, Mallory D Witt, Ken Ho, Chirag R Parikh, Mary Young, Anjali Sharma, Michael G Shlipak, Journal of the American Society of Nephrology
Press Mentions
The COVID-19 Vaccination Experience of Non-English Speaking Immigrant and Refugee Communities of Color: A Community Co-Created StudyOctober 25th, 2022- Researchers Report Trial Results of Rectal Microbicides at HIV R4P Virtual ConferenceFebruary 3rd, 2021
- 14 Aug Short Term PReP Can Help Protect Men from HIV During VacationAugust 14th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
